Atopic dermatitis: A practice parameter update 2012

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

卷:131

Article

Schneider, Lynda¹  Tilles, Stephen¹⁰  Lio, Peter^2,3  Boguniewicz, Mark^4,5  Beck, Lisa⁶  LeBovidge, Jennifer⁷  Novak, Natalija^8,9 

[1] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Pediat, Boston, MA USA

[2] Northwestern Univ, Feinberg Sch Med, Dept Clin Dermatol, Chicago, IL 60611 USA

[3] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA

[4] Natl Jewish Hlth, Dept Pediat, Denver, CO USA

[5] Univ Colorado Denver, Sch Med, Denver, CO USA

[6] Univ Rochester, Med Ctr, Dept Dermatol, Rochester, NY 14642 USA

[7] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Psychol, Boston, MA USA

[8] Univ Bonn, Dept Dermatol, Bonn, Germany

[9] Univ Bonn, Dept Allergy, Bonn, Germany

[10] Univ Washington, Sch Med, Dept Med, Redmond, WA USA

关键词: Atopic dermatitis/atopic eczema;    pathogenesis;    genetics;    diagnosis;    management;    therapy;    triggers;    Staphylococcus;    quality of life;    sleep;    cyclosporine;    immunomodulating agents;    phototherapy;    allergen immunotherapy;   

DOI  :  10.1016/j.jaci.2012.12.672

来源: Elsevier

【 摘 要 】

This parameter was developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma and Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing Atopic dermatitis: a practice parameter update 2012.'' This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion. Published practice parameters of the Joint Task Force on Practice Parameters for Allergy & Immunology are available online at http://www.jcaai.org. (J Allergy Clin Immunol 2013;131:295-9.)

【 授权许可】

Free